Table 3. Clinicopathological characteristics of the investigated HCC patients.
| Cohort 1 (n = 49) | Cohort 2 (n = 64) | |
|---|---|---|
| Characteristics | No. of patients (%) | No. of patients (%) |
| Gender | ||
| Male | 44 (85.7%) | 54 (83.7%) |
| Female | 5 (14.3%) | 10 (16.3%) |
| Age | ||
| < 54 | 22 (44.9%) | 30 (46.9%) |
| ≥ 54 | 27 (55.1%) | 34 (53.1%) |
| Tumor size | ||
| < 5 cm | 18 (36.7%) | 33 (51.5%) |
| ≥ 5 cm | 31 (63.3%) | 31 (48.5%) |
| Liver cirrhosis history | ||
| Yes | 42 (85.7%) | 51 (79.6%) |
| No | 7 (14.3%) | 13 (21.4%) |
| TNM stage | ||
| I | 11 (22.4%) | 25 (39.1%) |
| II | 23 (46.9%) | 14 (14.1%) |
| III | 15 (30.7%) | 21 (32.8%) |
| IV | 0 | 9 (13.2%) |
| Regional lymph nodes | ||
| N0 | 35 (71.4%) | 25 (39.1%) |
| N1 | 14 (28.6%) | 39 (60.9%) |
| BCLC stage | ||
| 0 | 4 (8.2%) | 14 (21.8%) |
| A | 20 (40.8%) | 19 (29.7%) |
| B | 10 (20.4%) | 8 (12.5%) |
| C | 14 (28.6%) | 23 (36.0%) |
| D | 1 (2.0%) | 0 |
| Distant metastasis | ||
| No | 28 (78.4%) | 20 (21.2%) |
| Yes | 9 (21.6%) | 44 (68.8%) |